Protokinetix, Inc. (PKTX)
0.0083
0.00 (0.00%)
USD |
OTCM |
Feb 12, 16:00
Protokinetix Cash from Investing (Quarterly) : -0.0056M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 1.297M |
| BioStem Technologies, Inc. | -1.168M |
| Iovance Biotherapeutics, Inc. | 17.01M |
| GB Sciences, Inc. | 0.00 |
| Travere Therapeutics, Inc. | 86.59M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.0039M |
| Cash from Financing (Quarterly) | 0.01M |
| Free Cash Flow | -0.2226M |
| Free Cash Flow to Equity (Quarterly) | -0.0095M |
| Free Cash Flow to Firm (Quarterly) | -0.0095M |
| Free Cash Flow Yield | -7.22% |